Search
for
Sort by
Research 781–810 of 1000+
- EFFECTS OF A LOW‐DOSE DESOGESTREL‐ETHINYLESTRADIOL COMBINATION ON HIRSUTISM, ANDROGENS AND SEX HORMONE BINDING GLOBULIN IN WOMEN WITH A POLYCYSTIC OVARY SYNDROME
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study
- Elevated Ghrelin Plasma Levels in Patients with Polycystic Ovary Syndrome
- Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Polycystic Ovary Syndrome: Early Detection in the Adolescent
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
- Mood disorders and quality of life in polycystic ovary syndrome